Another study promotes self-managed ‘TelAbortion’ as safe. Here’s why you should question that.

A TelAbortion study which promotes self-managed abortion via telemedicine has been accepted by the Journal Contraception, a publication staffed by abortion insiders which previously failed to disclose that previous studies were financed by a large investor of the abortion pill manufacturer, DANCO. (Read here about the secrecy behind DANCO’s operations and its ties to groups and original investors which seek to expand abortion.) Given its publication in a pro-abortion journal, the study, “TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States,” unsurprisingly lands favorably on the side of distributing abortion medication remotely to women without a physician exam:

This direct-to-patient telemedicine abortion service was safe, effective, efficient, and satisfactory. The model has the potential to increase abortion access by enhancing the reach of providers and by offering people a new option for obtaining care conveniently and privately.

… But an in-depth look into who’s behind the study should cast tremendous doubt on its findings.

Contraception is the official journal of the Association of Reproductive Health Professionals (ARHP) and the Society of Family Planning (SFP). So exactly who are the AHRP and the SFP? Live Action News reveals what mainstream media won’t, and will show why it’s important never to take studies or polls at simple face value.

1. The Society of Family Planning (SFP) is part of the abortion study team, runs the Contraception Journal, and funds pro-abortion advocacy organizations.

• Society of Family Planning (SFP) is part of the TelAbortion study team.

• SFP’s mission supports research on abortion.

• SFP founding member Mark Nichols, MD, was “local principal investigator in the initial Population Council trial investigating mifepristone [abortion pill] for first trimester abortion leading to FDA approval.”

• SFP funds Guttmacher Institute, a former “special affiliate” of Planned Parenthood which promotes self-managed abortion.

Society of Family Planning mission is abortion research

2. The Association of Reproductive Health Professionals (ARHP) also runs Contraception and was originally an educational arm of Planned Parenthood.

ARHP was founded as clinical education arm of Planned Parenthood under the American Association of Planned Parenthood Physicians (AAPPP) in 1963 by Planned Parenthood president, Alan Guttmacher, and has gone through multiple name changes. Guttmacher was former VP of Eugenics Society and a past Planned Parenthood president.

Today, the website appears to be undergoing changes. At quick glance, this information no longer appears to be available or has been scrubbed.

A cached version from 2018 and an additional cached versions confirms the history.

3. The Journal Contraception has repeatedly failed to note past conflicts of interest and is run by abortionists with a vested financial interest in abortion’s expansion.

• Founded in 1970 by Daniel R. Mishell, Jr.

• Has failed to note glaring conflicts of interests in the past, namely that funding came from the David and Lucile Packard Foundation, a major investor in the abortion pill manufacturer, DANCO.

• Editorial board stacked with abortion industry insiders, including a National Abortion Federation board member and members of Population Council (responsible for bringing the abortion pill into US, forming DANCO).

• Current editor is abortionist Dr. Carolyn Westhoff, former director at ARHP, involved in original 

Packard Foundation self managed abortion pill study (Image: 2018 study from Journal Contraception)

Previous Packard-funded studies in this journal unsurprisingly supported the pro-abortion cause, claiming self-managed abortion is safe, and urging the undoing of current FDA safety standards (known as REMS) restricting dispensation of the abortion pill Mifeprex.

Recently, the FDA updated its adverse effects reports through 2018, revealing 24 deaths of women associated with the abortion pill since its September 2000 approval. To date, the report documents nearly 4,200 reported adverse effects, including hospitalization and other serious complications. Under 2016 changes, the drug’s manufacturer, DANCO, no longer has to report non-fatal adverse effects, so we can only imagine what the number really is.

More on who financed the study in an upcoming article.

Editor’s Note: FDA has received reports of serious adverse events in women who took mifepristone. As of June 30, 2021, there were reports of 26 deaths of women associated with mifepristone since the product was approved in September 2000, including two cases of ectopic pregnancy (a pregnancy located outside the womb, such as in the fallopian tubes) resulting in death; and several cases of severe systemic infection (also called sepsis), including some that were fatal. The adverse events cannot with certainty be causally attributed to mifepristone because of concurrent use of other drugs, other medical or surgical treatments, co-existing medical conditions, and information gaps about patient health status and clinical management of the patient. A summary report of adverse events that reflects data through June 30, 2021 is here.

“Like” Live Action News on Facebook for more pro-life news and commentary!